In acral melanomas there is a relationship between PTEN loss and amplification of the AMPK-related kinase NUAK2; importantly, in these melanomas, the presence of both PTEN loss and NUAK2 amplification was associated with poor prognosis [63]. This evidence concerns the gene PTEN and acral lentiginous melanoma.